How big is the Breast Biopsy Devices Market?

The Breast Biopsy Devices Market size is expected to reach USD 1.23 billion in 2024 and grow at a CAGR of 5.12% to reach USD 1.58 billion by 2029. Read More

What is the current Breast Biopsy Devices Market size?

In 2024, the Breast Biopsy Devices Market size is expected to reach USD 1.23 billion. Read More

Who are the key players in Breast Biopsy Devices Market?

F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Danaher Corporation and Merit Medical Systems are the major companies operating in the Breast Biopsy Devices Market. Read More

Which is the fastest growing region in Breast Biopsy Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2029). Read More

Which region has the biggest share in Breast Biopsy Devices Market?

In 2023, the North America accounts for the largest market share in Breast Biopsy Devices Market. Read More

What years does this Breast Biopsy Devices Market cover, and what was the market size in 2023?

In 2023, the Breast Biopsy Devices Market size was estimated at USD 1.17 billion. The report covers the Breast Biopsy Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Breast Biopsy Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Breast Biopsy Devices Market Share

Statistics for the 2023 & 2024 Breast Biopsy Devices market share, created by Mordor Intelligence™ Industry Reports. Breast Biopsy Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Breast Biopsy Devices Industry

The breast biopsy devices market is moderately consolidated and competitive due to the presence of many players. The market's major players are concentrating on joint ventures, strategic alliances, the introduction of new products, and geographic growth into developing and economically advantageous areas. Some of the major players include F. Hoffmann-La Roche Ltd, Ferring B.V., Hologic Inc., Danaher Corporation, Argon Medical Devices, Merit Medical Systems, Menarini-Silicon Biosystems, NeoGenomics, Sterylab S.R.L., Bio-Rad Laboratories, Inc., Qiagen, Exact Sciences Corporation, Sysmex Inostics, Becton Dickinson and Company, Guardant Health, Inc.